Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-25-083321

Director sold 3 shares at $30.48 ($91)

From the SEC's structured data for this filing

Trades in this filing

GANNON STEVEN · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-05 Sale : show line 1 in the form −3 $30.48 $91 7,141 D
Open-market sales · 3 sh · avg $30.48 · $91

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-06-05 Grant or award : show line 2 in the form Share Option (Right to Buy) +17,012 17,012 D
2025-06-05 Grant or award : show line 3 in the form Restricted Share Units +2,645 2,645 D
Loading xslF345X05/ownership.xml…